Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Astec Industries | ASTE | Nov 14, 2024 | 37.28 | -0.61 |
Astera Labs | ALAB | Nov 14, 2024 | 88.49 | -0.91 |
Astrana Health | ASTH | Nov 14, 2024 | 41.90 | -0.02 |
AstraZeneca ADR | AZN | Nov 14, 2024 | 65.04 | -0.38 |
Astria Therapeutics | ATXS | Nov 14, 2024 | 10.09 | -4.90 |
Astronics | ATRO | Nov 14, 2024 | 16.28 | -1.33 |
AstroNova | ALOT | Nov 14, 2024 | 14.24 | -0.07 |
Astrotech | ASTC | Nov 14, 2024 | 6.85 | -2.14 |
Asure Software | ASUR | Nov 14, 2024 | 8.65 | -5.26 |
AT&T | T | Nov 14, 2024 | 22.25 | -0.22 |
AT&T A Pref | T-A | Nov 14, 2024 | 21.42 | 0.00 |
AT&T C Pref | T-C | Nov 14, 2024 | 20.23 | -0.20 |
ATA Creativity Global ADR | AACG | Nov 14, 2024 | 1.02 | -1.07 |
Atai Life Sciences BV | ATAI | Nov 14, 2024 | 1.37 | +1.48 |
Atara Biotherapeutics | ATRA | Nov 14, 2024 | 12.77 | -10.45 |
Atea Pharmaceuticals | AVIR | Nov 14, 2024 | 3.31 | -1.19 |
Aterian | ATER | Nov 14, 2024 | 2.76 | -2.13 |
Athena Technology Acquisition II | ATEK | Nov 14, 2024 | 11.72 | +0.09 |
Athene A Pref | ATH-A | Nov 14, 2024 | 24.99 | +0.44 |
Athene B Pref | ATH-B | Nov 14, 2024 | 21.89 | -0.32 |
Athene C Pref | ATH-C | Nov 14, 2024 | 25.28 | +0.24 |
Athene D Pref | ATH-D | Nov 14, 2024 | 18.90 | -0.94 |
Athene Holding | ATH-E | Nov 14, 2024 | 27.16 | 0.00 |
Athira Pharma | ATHA | Nov 14, 2024 | 0.71 | -2.22 |
Ati Physical Therapy A | ATIP | Nov 14, 2024 | 2.13 | -6.17 |
ATIF Holdings | ATIF | Nov 14, 2024 | 0.68 | -2.86 |
Atkore | ATKR | Nov 14, 2024 | 91.23 | -1.35 |
Atlanta Braves A | BATRA | Nov 14, 2024 | 42.98 | +1.63 |
Atlanta Braves C | BATRK | Nov 14, 2024 | 40.98 | +1.66 |
Atlantic American | AAME | Nov 14, 2024 | 1.70 | -0.87 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.